Test results: characterising the antimicrobial activity of daptomycin

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,

G. Cornaglia, A. Lönnroth, M. Struelens

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Management of multidrug-resistant enterococcal infections

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995 Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,

R. Cantón Clinical Microbiology and Infection

Genital Chlamydia trachomatis infections

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure Y.-C. Wang, Y.-T.

J.-P. Stahl Clinical Microbiology and Infection

J. Cairo, R. Hachem, G. Rangaraj, B. Granwehr, I. Raad

Genome-based insights into the evolution of enterococci

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

P. Davey, C. Pagliari, A. Hayes Clinical Microbiology and Infection

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi

Vector control: a cornerstone in the malaria elimination campaign

Sofie Arens, Jan Verhaegen, Ludo Verbist

A. Oliver, A. Mena Clinical Microbiology and Infection

Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.

Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia S.-C. Kuo, Y.-T. Lee,

B. Gordts Clinical Microbiology and Infection

Strategies for managing today's infections

Comparison of clinical and environmental isolates of Legionella pneumophila obtained in the UK over 19 years T.G. Harrison, N. Doshi, N.K. Fry, C.A.

Microbiological and epidemiological studies of Enterococcus faecium resistant to amoxycillin in a university hospital in eastern France M. Thouverez,

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals H. von.

J. Garau Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Update on antifungal resistance in Aspergillus and Candida

Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients C.-H.

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Can β-lactams be re-engineered to beat MRSA?

Abstracts cont. Clinical Microbiology and Infection

A.W. Karchmer Clinical Microbiology and Infection

Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan

The dynamic relationship between antibiotic use and the incidence of vancomycin- resistant Enterococcus: time-series modelling of 7-year surveillance data.

Current experience in treating invasive zygomycosis with posaconazole

Reducing antibiotic use in influenza: challenges and rewards

Fibronectin concentrations in catheter sepsis

Vancomycin resistance emerging in a clonal outbreak caused by ampicillin-resistant Enterococcus faecium Stig Harthug, A. Digranes, O. Hope, B.E. Kristiansen,

Antimicrobial drug development – the past, the present, and the future

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

An after-hours clinical liaison blood culture service—is it worth it?

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

E. Tacconelli Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

C. Novais, T.M. Coque, J.C. Sousa, L.V. Peixe

Abstracts Clinical Microbiology and Infection

New oral cephalosporins in pediatric community-acquired infections

Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci V. Sakka, S. Tsiodras, L. Galani, A. Antoniadou,

Carratalà J. Clinical Microbiology and Infection

Are we losing the fight against malaria one more time?

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

The future of diagnostic bacteriology

Presentation transcript:

Test results: characterising the antimicrobial activity of daptomycin B. Wiedemann Clinical Microbiology and Infection Volume 12, Pages 9-14 (January 2006) DOI: 10.1111/j.1469-0691.2006.01625.x Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Activity of daptomycin and other antibiotics in biofilms. The activity of daptomycin (DAP), minocycline (MIN), quinupristin-dalfopristin (Q-D) and linezolid (LIN) was tested against bacteria in biofilms generated from vancomycin-resistant Enterococcus faecium isolates obtained from patients with catheter-related bacteraemia. Data represent the reduction in number of CFUs measured following the addition of each antibiotic. Adapted from Raad et al. 2005 [23]. Clinical Microbiology and Infection 2006 12, 9-14DOI: (10.1111/j.1469-0691.2006.01625.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Stages in the development of antibiotic resistance. Clinical Microbiology and Infection 2006 12, 9-14DOI: (10.1111/j.1469-0691.2006.01625.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions